https://magazine.pharmamkt.net/2019/05/01/triumvira-submits-investigational-new-drug-ind-application-to-the-fda-and-clinical-trial-application-cta-to-health-canada-to-evaluate-tac01-cd19-a-t-cell-antigen-coupler-therapy-in-ph-1-2-tactic/